Cargando…

Role of fluoroquinolone prophylaxis in allogeneic hematopoietic cell transplantation in regions with a high prevalence of fluoroquinolone resistance

INTRODUCTION: The role of fluoroquinolone (FQ) prophylaxis in preventing gram-negative bacilli (GNB) bacteremia, graft-versus-host disease (GVHD), and overall survival (OS) after allogeneic hematopoietic cell transplantation (allo-HCT) is debatable and may differ in settings with low and high preval...

Descripción completa

Detalles Bibliográficos
Autores principales:	Nair, Ashwin, Kaundal, Shaweta, Kasudhan, Kripa Shanker, Chopra, Madhu, Singh, Charanpreet, Jandial, Aditya, Jain, Arihant, Prakash, Gaurav, Khadwal, Alka, Angrup, Archana, Patil, Amol, Ray, Pallab, Malhotra, Pankaj, P Lad, Deepesh
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Asia-Pacific Blood and Marrow Transplantation Group 2023
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10279926/ https://www.ncbi.nlm.nih.gov/pubmed/37346770 http://dx.doi.org/10.31547/bct-2022-020

Ejemplares similares

Utility of eGVHD App for bedside GVHD assessment in a high-volume BMT center
por: Chhabra, Prashant, et al.
Publicado: (2023)

Adherence to long-term follow-up preventive practices in allogeneic hematopoietic cell transplantation survivors from North India
por: Khaire, Niranjan S., et al.
Publicado: (2022)

Short Research Communication Anti-Spike Antibody Response to COVISHIELD™ (SII-ChAdOx1 nCoV-19) Vaccine in Patients with B-Cell and Plasma Cell Malignancies and Hematopoietic Cell Transplantation Recipients
por: Chopra, Madhu, et al.
Publicado: (2022)

Improving outcomes for high-risk DLBCL: a pilot study looking at the role of fractionated cyclophosphamide with RCHOP chemo-immunotherapy (SCUBA-1 trial)
por: Singh, Charanpreet, et al.
Publicado: (2022)

Early bone loss in Indian patients undergoing allogeneic hematopoietic cell transplantation
por: Khaire, Niranjan S., et al.
Publicado: (2021)

Feasibility of treatment-free remission with generic imatinib: Results of generic imatinib-free trial-in-chronic myeloid leukaemia-chronic phase study
por: Goni, Deepak, et al.
Publicado: (2023)

Bendamustine in combination with ifosfamide, etoposide, and vinorelbine (VIBE) is an effective salvage regimen for heavily pre-treated patients with relapsed or refractory Hodgkin lymphoma: a single-center experience
por: Prakash, Gaurav, et al.
Publicado: (2021)

Protective role of Convolvulus pluricaulis on lipid abnormalities in high-fat diet with low dose streptozotocin-induced experimental rat model
por: Garg, Gaurav, et al.
Publicado: (2020)

A Phase 2 Randomized Controlled Trial of Single-Agent Hydroxyurea Versus Thalidomide Among Adult Transfusion Dependent β Thalassemia Patients
por: Bhattacharjee, Urmimala, et al.
Publicado: (2023)

How to Use a Prioritised Approach for Treating Hematological Disorders During the COVID-19 Pandemic in India?
por: Jain, Arihant, et al.
Publicado: (2020)

Chronic Lymphocytic Leukemia: Real-World Data From India
por: Tejaswi, V., et al.
Publicado: (2020)

Etymologia: Fluoroquinolone
por: Henry, Ronne
Publicado: (2017)

High fluoroquinolone MIC is associated with fluoroquinolone treatment failure in urinary tract infections caused by fluoroquinolone susceptible Escherichia coli
por: Rattanaumpawan, Pinyo, et al.
Publicado: (2017)

Corneal plates of fluoroquinolone
por: El Mellaoui, Mohammed, et al.
Publicado: (2014)

Rapid evolution of fluoroquinolone-resistant Escherichia coli in Nigeria is temporally associated with fluoroquinolone use
por: Lamikanra, Adebayo, et al.
Publicado: (2011)

Hypersensitivity to fluoroquinolones: The expression of basophil activation markers depends on the clinical entity and the culprit fluoroquinolone
por: Fernández, Tahia D., et al.
Publicado: (2016)

Factors Influencing Fluoroquinolone Resistance
por: Sahm, Daniel F., et al.
Publicado: (2003)

Fluoroquinolone resistance in Neisseria gonorrhoeae.
por: Knapp, J S, et al.
Publicado: (1997)

Fluoroquinolone Use in Food Animals
por: Collignon, Peter
Publicado: (2005)

Fluoroquinolone-resistant Streptococcus pneumoniae
por: Pletz, Mathias W.R., et al.
Publicado: (2006)

Emerging mechanisms of fluoroquinolone resistance.
por: Hooper, D C
Publicado: (2001)

Systemic use of fluoroquinolone in children
por: Choi, Soo-Han, et al.
Publicado: (2013)

Reproductive toxicity of fluoroquinolones in birds
por: Hruba, Hana, et al.
Publicado: (2019)

Trends in fluoroquinolone resistance in Campylobacter
por: Sproston, Emma L., et al.
Publicado: (2018)

Herbicidal activity of fluoroquinolone derivatives
por: Wallace, Michael D., et al.
Publicado: (2021)

Fluoroquinolone antibiotics and adverse events
por: Baggio, Diva, et al.
Publicado: (2021)

How Safe are Fluoroquinolones for Diabetic Patients? A Systematic Review of Dysglycemic and Neuropathic Effects of Fluoroquinolones
por: Althaqafi, Abdulrhman, et al.
Publicado: (2021)

Analysis of fluoroquinolones in dusts from intensive livestock farming and the co-occurrence of fluoroquinolone-resistant Escherichia coli
por: Schulz, Jochen, et al.
Publicado: (2019)

Emergence of Fluoroquinolone-Resistant Campylobacter jejuni and Campylobacter coli among Australian Chickens in the Absence of Fluoroquinolone Use
por: Abraham, Sam, et al.
Publicado: (2020)

Fluoroquinolone-Resistant Typhoid, South Africa
por: Keddy, Karen H., et al.
Publicado: (2010)

Fluoroquinolone-resistant Escherichia coli, Indonesia
por: Kuntaman, Kuntaman, et al.
Publicado: (2005)

Fluoroquinolone Resistance and Clostridium difficile, Germany
por: Zaiß, Nils Henning, et al.
Publicado: (2010)

Fluoroquinolone-resistant Salmonella Paratyphi A
por: Adachi, Takuya, et al.
Publicado: (2005)

Fluoroquinolone-resistant Salmonella sp. in Carcasses
por: Wang, Yu-Chih, et al.
Publicado: (2006)

Fluoroquinolones: An under-recognized cause for delirium
por: Chowdhry, Vivek, et al.
Publicado: (2015)

Nonantibiotic Effects of Fluoroquinolones in Mammalian Cells
por: Badal, Sujan, et al.
Publicado: (2015)

The Role of Fluoroquinolones in the Treatment of Tuberculosis in 2019
por: Pranger, A. D., et al.
Publicado: (2019)

Evaluation of disability in patients exposed to fluoroquinolones
por: Wilcox, Marsha A., et al.
Publicado: (2020)

Fluoroquinolones and Aortic Diseases: Is There a Connection
por: Carino, Davide, et al.
Publicado: (2019)

1787. County Level Association Between the Rate of Fluoroquinolone-Resistance Gram Negative Bacteria and Fluoroquinolone Utilization in Kansas
por: Fulmer, Robert D, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_12hq6gf50i59cfq7q3oehrb65s